Straumann Holding (SAUHY) Fair Value & Analysis
Healthcare · US · Market cap $21.3B
Straumann Holding
SAUHY · US
Fair value as of: Jun 24, 2026
From 26 valuation models · updated 11 days ago
Fair value updated Jun 24, 2026 — revised from $5.51 to $5.49 (−0.4%) since Jun 23, 2026. Share price +10.3% over the past month.
Price vs Fair Value (12 months)
12‑month range $9.17 – $13.16 · fair‑value band $3.34 – $7.57 · the $12.68 price screens above the $5.49 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Straumann Holding (SAUHY) currently trades at $12.68, while our model-based Fair Value estimate is $5.49 — implying the stock looks roughly 56.7% overvalued today. We read business quality at 63/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Straumann Holding generated revenue of $2.6B at a net margin of 13.7%. Revenue grew 2.2% year over year. It earns a return on equity of 17.0%. Net debt stands at $175M. Fundamentals as of Jun 24, 2026
Our scenario range runs from $3.34 (bear case) to $7.57 (bull case); at $12.68, the current price sits above that range. The share trades about 7% below its 52-week high and 33% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -43% fair-value upside — at -57%, SAUHY screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Straumann Holding AG provides tooth replacement and orthodontic solutions in Switzerland, the United States, China, Germany, Brazil, Japan, France, and internationally. It operates through Sales Europe, Middle East and Africa; Sales North America; Sales Asia Pacific; Sales Latin America; and Operations segments. The company offers dental implants, instruments, CADCAM prosthetics, orthodontic and clear aligners, biomaterials, and digital equipment and solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. It also provides implant systems, components, and related instruments, as well as healing components, materials and surfaces, surgical sets and instruments, and guided surgery and navigation products; prosthetics, including angled solutions, connections, components, and molar solutions; intra-oral and lab scanners, milling machines, dynamic navigation systems, and 3D printers; consumables, such as blocks, discs, resins, titanium …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Straumann Holding reported revenue of $2.6B in FY2025 versus $2.0B in FY2021, a compound +6.5%/yr. Reported net income was $356M in FY2025, compounding −2.6%/yr from FY2021.
Is SAUHY fairly valued? → Check now
Recent news
- ALGN or SAUHY: Which Is the Better Value Stock Right Now?
- COO or SAUHY: Which Is the Better Value Stock Right Now?
- Clear Aligner Market Report: 2026 Edition Now Available
- COO vs. SAUHY: Which Stock Is the Better Value Option?
External third-party headlines (Yahoo Finance, Reuters and others) — not an editorial selection, not financial advice.
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $402.95 | $182.39 | -55% |
| EssilorLuxottica Société anonyme ESLOF | $190.25 | $125.65 | -34% |
| HOYA Corporation HOCPY | $168.16 | $96.16 | -43% |
| Medline Inc MDLN | $34.71 | $30.15 | -13% |
| Becton, Dickinson and Company BDX | $149.56 | $117.04 | -22% |
| Alcon Inc ALC | $66.58 | $36.99 | -44% |
| ResMed Inc R1MD34 | R$260.00 | R$32.27 | -88% |
| West Pharmaceutical Services, Inc WST | $330.92 | $114.00 | -66% |
| Terumo Corporation TRUMF | $14.62 | $12.65 | -13% |
| Sartorius Stedim Biotech S.A DIM | €178.60 | €34.61 | -81% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Straumann Holding (SAUHY) undervalued?
What is the fair value of SAUHY?
What is the quality score of SAUHY?
What is the revenue of Straumann Holding (SAUHY)?
What is the net profit margin of SAUHY?
Does Straumann Holding pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.